期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗组胺药物治疗变应性鼻炎的评价和使用建议 被引量：6

原文传递
导出
摘要 抗组胺药物在治疗变应性鼻炎（AR）及变应性哮喘方面具有不可替代的作用,但怎样发挥最佳效果又能避免副作用（中枢镇静、心脏毒性等）,变态反应学家、药理学家、国际组织、药物生产厂家都进行了不懈的努力,各种研究和探索为患者和医师带来了知识更新和切实利益。
作者 王洪田 张静
机构地区 解放军总医院耳鼻咽喉头颈外科
出处 《中国医学文摘（耳鼻咽喉科学）》 2011年第5期235-238,共4页 Chinese Medical Digest(Otorhinolaryngology)
关键词 组胺H1拮抗剂(Histamine H1 Antagonists) 药物评价(Drug Evaluation) 指南[文献类型](Guidebooks[Publication Type])
分类号 R765.21 [医药卫生—耳鼻咽喉科]
  • 相关文献

参考文献19

  • 1程雷.H1抗组胺药和鼻内糖皮质激素治疗变应性鼻炎对哮喘的影响[J].中国医学文摘（耳鼻咽喉科学）,2009,24(4):204-207. 被引量：3
  • 2游学俊,刘争,徐凯,高起学,崔永华.地氯雷他定治疗季节性变应性鼻炎疗效及安全性观察[J].临床耳鼻咽喉头颈外科杂志,2008,22(8):382-384. 被引量：18
  • 3邓安春,杨桦,镡旭民,周世文,应懿.盐酸非索非那定片治疗变应性鼻炎多中心随机双盲对照临床试验[J].中国临床药理学杂志,2005,21(5):332-335. 被引量：3
  • 4Bousquet J,Van Cauwenberge P,Khaltaev N,et al.Allergic rhinitis and its impact on asthma. Journal of Allergy and Clinical Immunology,The . 2001
  • 5Grant JA,Riethuisen JM,Moulaert B,et al.A double-blind,randomized,single-dose,crossover comparison of levocetirizine with ebastine,fexofenadine,loratadine,mizolastine,and placebo:suppression of histamine-induced wheal-and-flare response dur-ing24hours in healthy male subjects. Ann Allergy Asthma Immunol . 2002
  • 6Simpson K,Jarvis B.Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs . 2000
  • 7KENNETH K,GORDON S,JACQUES H,et al.Desloratadine therapy for symptoms associated withperennial allergic rhinitis. Annals of Allergy Asthma Immunology . 2006
  • 8Thurmond RL,Gelfand EW,Dunford PJ.The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nature Reviews Drug Discovery . 2008
  • 9Meeves SG,Appajosyula S.Efficacy and safety profile of fexofenadine HCl:a unique therapeutic option in H1-receptor antagonist treatment. Allergy and Clinical Immunology International . 2003
  • 10Passalacqua G,Compalati E,Canonica GW.Investigational drugs for allergic rhinitis. Expert Opinion on Investigational Drugs . 2010

二级参考文献41

  • 1晋展.抗变态反应药Desloratadine[J].药学进展,2002,26(1):62-63. 被引量：2
  • 2陈继川,姬长友,蒋耀光,李雪蕾,陈亮,傅若秋.盐酸左西替利嗪对124例变应性鼻炎的前瞻性临床研究[J].重庆医学,2006,35(4):364-366. 被引量：16
  • 3Salib RJ, Drake-Lee A, Howarth PH. Allergic rhinitis: past, present and the future[J]. Clin-Otolaryngol, 2003, 28:291-303.
  • 4Berger WE. Overview of allergic rhinitis[ J ]. Ann Allergy Asthma Immunol, 2003,90(6 Suppl. 3): S7 - S12.
  • 5Gelfand EW, Appajosyula S, Meeves S. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research[J].Curr Med Res Opin, 2004,20:73-81.
  • 6Amichai B, Grunwald MH, Brenner L. Fexofenadine hydrochloride-a new anti-histaminic drug[ J ]. Isr Med Assoc J, 2001,3:207 - 209.
  • 7Meeves SG, Appajosyula S. Efficacy and safety profile of fexofenadine HCI: a unique therapeutic option in H1-receptor antagonist treatment[J]. J Allergy Clin Immunol, 2003, 112(4 Suppl.): S69 - S77.
  • 8Armstrong SC, Cozza KL. Antihistamines[J]. Psychosomatics, 2003,44: 430-434.
  • 9Yap YG, Camm AJ. Potential cardiac toxicity of H1-antihistamines[J]. Clin Allergy Immunol, 2002, 17: 389-419.
  • 10Philpot EE. Safety of second generation antihistamines[J]. Allergy Asthma Proc, 2000, 21: 15-20.

共引文献20

同被引文献65

  • 1瞿申红,李添应,陈彦球,林志斌,欧志英.白三烯受体拮抗剂和吸入性皮质激素在变应性鼻炎中的应用[J].临床耳鼻咽喉科杂志,2005,19(12):557-559. 被引量：14
  • 2彭秋莹,陈爱欢.白三烯研究进展及其在婴幼儿喘息性疾病中的作用[J].中华儿科杂志,2006,44(7):553-556. 被引量：94
  • 3罗鸿,刘胜武,龚树生.类固醇抵抗型变应性鼻炎[J].国际耳鼻咽喉头颈外科杂志,2007,31(2):90-93. 被引量：12
  • 4Salapatek AM, Lee J, Patel D, et ai. Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis. Allergy Asthma Proc, 2011, 32: 221-229.
  • 5LaForce CF, Carr W, Tilles SA, et al. Evaluation of olopatadine dydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. Allergy Asthma Proc, 2010, 31: 132-140.
  • 6Ratner PH, Hampel F, Van Bavel J, et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 2008, 100: 74-81.
  • 7Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, place- bo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol, 2010, 105: 168-173.
  • 8SalapatekA, D'Angelo P, Bates M, et al. Novel combination product Captisol-enabled budesonide azelastinehcl provides fast, long-lasting relief of allergic rhinitis symptoms total nasal symptom score (TNSS) and individual nasal symptoms scores (NSS) in ragweed allergic patients studied in an environmental exposure chamber (EEC) model. J Allergy Clin Immunol, 2009, 123: S130.
  • 9Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol, 2010, 126: 466-476.
  • 10Meltzer EO, LaForce C, Ratner P, et al. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc, 2012, 33: 324-332.

引证文献6

二级引证文献16

中国医学文摘（耳鼻咽喉科学）
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部